ADA 2022 Wrap Up: Iterative Progress On Glucose Control, No Big Surprises
The major players in the diabetes tech sector announced new and re-hashed old clinical data at this year’s American Diabetes Association Scientific Sessions in New Orleans.
You may also be interested in...
Insulet widens the launch of its Omnipod 5 automated insulin delivery system with the FDA clearance for children ages 2 and up. Previously, the system was available to people aged 6 years and older.
Are digital solutions the missing link for diabetes care? Glooko and Omada Health think so. Both have developed device-integrating platforms to help patients manage their condition.
Shortly after the FDA approved Abbott's FreeStyle Libre 3 continuous glucose monitor system, the company announced new clinical data showing that it is the most accurate 14-day CGM system available.